Full Prescribing Information
Important Safety Information
For Healthcare Professionals

Don’t Wait Until It’s Too Late

Early detection and treatment is critical 1-3, 20

5-FU and capecitabine toxicity can happen early and move quickly

Severe or life-threatening symptoms of toxicity can start as early as Day 1 of chemotherapy. They may also begin several days following the completion of chemotherapy on Day 4.

Help your patients understand the urgency of early detection and treatment.

 Prepare Together Encourage Self-Monitoring Remind them that you're listening Reassure them that they shouldn't worry

Prepare Together.

Start a dialogue with your patients and their caregivers.

Talk to your patients about 5-FU and capecitabine toxicity before your patients begin chemotherapy.

Download the Patient
Education Poster

Encourage
Self-Monitoring.

Encourage self-monitoring for symptoms of toxicity and inform family and caregivers about the signs and symptoms so they can help monitor during the critical window of during and following completion of chemotherapy.

Download the Colon Cancer
Alliance Fact Sheet

Remind them that you're listening.

Encourage them to call.

Encourage them to call and talk to their cancer care team as soon as they suspect they are experiencing symptoms of a toxic reaction, even if they are unsure about symptoms. Remind them that it’s important to speak up so that their cancer care team can take action immediately.

Download the Patient
Reminder Card

Reassure them that they shouldn't worry.

Treatment is available.

5-FU and capecitabine toxicity is treatable. Vistogard® (uridine triacetate) is the first and only antidote for the treatment of 5-FU and capecitabine toxicity. In clinical trials, 96% of patients treated with Vistogard® survived 5-FU or capecitabine toxicity. 1, 2,19

Download the Patient
Education Brochure

Vistogard

Stop 5-FU or capecitabine toxicity in its tracks 1-3, 19, 21-23

Severe or life-threatening toxicity caused by 5-FU or capecitabine chemotherapy can be stopped with an antidote therapy called Vistogard® (uridine triacetate).

With early detection and treatment with Vistogard®, 96% patients in clinical trials survived severe 5-FU or capecitabine toxicity.

Learn more here

Do your patients understand what’s happening during a toxic reaction?

We understand that early detection and treatment is key to alleviating and stopping 5-FU and capecitabine toxicity. 1, 2, 19, 20 However, your patients may not understand or may not be prepared to tell you that they need critical care.

 TALK ABOUT NORMAL SIDE EFFECTS  TALK ABOUT THE SIGNS OF TOXICITY